Trial intelligence / Profile preview

Effect of Delayed-Release Ox Bile Extract in Overweight or Obese Patients With Type 2 Diabetes

NCT02871882Phase 2Completed

Sponsor
Mayo Clinic
Start
Sep 2016
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in type 2 diabetes mellitus (T2DM) comparing Ox bile extract with Placebo (2 arms). Primary endpoint: Change in Postprandial Glucose at 1 month. Started Sep 2016; status: completed.

02

Drugs

ox bile extract
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02871882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02871882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call